The Microwave Imaging Radiometer using Aperture Synthesis (MIRAS) on board the European Space Agency's (ESA) Soil Moisture and Ocean Salinity (SMOS) mission for the first time measures globally ...Earth's radiation at a frequency of 1.4 GHz (L‐band). It had been hypothesized that L‐band radiometry can be used to measure the sea ice thickness due to the large penetration depth in the sea ice medium. We demonstrate the potential of SMOS to derive the thickness of thin sea ice for the Arctic freeze‐up period using a novel retrieval algorithm based on Level 1C brightness temperatures. The SMOS ice thickness product is compared with an ice growth model and independent sea ice thickness estimates from MODIS thermal infrared imagery. The ice thickness derived from SMOS is highly consistent with the temporal development of the growth simulation and agrees with the ice thickness from MODIS images with 10 cm standard deviation. The results confirm that SMOS can be used to retrieve sea ice thickness up to half a meter under ideal cold conditions with surface air temperatures below −10°C and high‐concentration sea ice coverage.
Key Points
SMOS can be used to retrieve sea ice thickness up to half a meter in the Arctic
SMOS sea ice thickness agrees with independent validation data
The brightness temperature and thickness relation is justified
Following the launch of ESA's Soil Moisture and Ocean Salinity (SMOS) mission, it has been shown that brightness temperatures at a low microwave frequency of 1.4 GHz (L-band) are sensitive to sea ice ...properties. In the first demonstration study, sea ice thickness up to 50 cm has been derived using a semi-empirical algorithm with constant tie-points. Here, we introduce a novel iterative retrieval algorithm that is based on a thermodynamic sea ice model and a three-layer radiative transfer model, which explicitly takes variations of ice temperature and ice salinity into account. In addition, ice thickness variations within the SMOS spatial resolution are considered through a statistical thickness distribution function derived from high-resolution ice thickness measurements from NASA's Operation IceBridge campaign. This new algorithm has been used for the continuous operational production of a SMOS-based sea ice thickness data set from 2010 on. The data set is compared to and validated with estimates from assimilation systems, remote sensing data, and airborne electromagnetic sounding data. The comparisons show that the new retrieval algorithm has a considerably better agreement with the validation data and delivers a more realistic Arctic-wide ice thickness distribution than the algorithm used in the previous study (Kaleschke et al., 2012).
The microwave interferometric radiometer of the European Space Agency's Soil Moisture and Ocean Salinity (SMOS) mission measures at a frequency of 1.4 GHz in the L-band. In contrast to other ...microwave satellites, low frequency measurements in L-band have a large penetration depth in sea ice and thus contain information on the ice thickness. Previous ice thickness retrievals have neglected a snow layer on top of the ice. Here, we implement a snow layer in our emission model and investigate how snow influences L-band brightness temperatures and whether it is possible to retrieve snow thickness over thick Arctic sea ice from SMOS data. We find that the brightness temperatures above snow-covered sea ice are higher than above bare sea ice and that horizontal polarisation is more affected by the snow layer than vertical polarisation. In accordance with our theoretical investigations, the root mean square deviation between simulated and observed horizontally polarised brightness temperatures decreases from 20.9 K to 4.7 K, when we include the snow layer in the simulations. Although dry snow is almost transparent in L-band, we find brightness temperatures to increase with increasing snow thickness under cold Arctic conditions. The brightness temperatures' dependence on snow thickness can be explained by the thermal insulation of snow and its dependence on the snow layer thickness. This temperature effect allows us to retrieve snow thickness over thick sea ice. For the best simulation scenario and snow thicknesses up to 35 cm, the average snow thickness retrieved from horizontally polarised SMOS brightness temperatures agrees within 0.1 cm with the average snow thickness measured during the IceBridge flight campaign in the Arctic in spring 2012. The corresponding root mean square deviation is 5.5 cm, and the coefficient of determination is r2 = 0.58.
In preparation for the European Space Agency's (ESA) Soil Moisture and Ocean Salinity (SMOS) mission, we investigated the potential of L-band (1.4 GHz) radiometry to measure sea-ice thickness. ...Sea-ice brightness temperature was measured at 1.4 GHz and ice thickness was measured along nearly coincident flight tracks during the SMOS Sea-Ice campaign in the Bay of Bothnia in March 2007. A research aircraft was equipped with the L-band Radiometer EMIRAD and coordinated with helicopter based electromagnetic induction (EM) ice thickness measurements. We developed a three layer (ocean-ice-atmosphere) dielectric slab model for the calculation of ice thickness from brightness temperature. The dielectric properties depend on the relative brine volume which is a function of the bulk ice salinity and temperature. The model calculations suggest a thickness sensitivity of up to 1.5 m for low-salinity (multi-year or brackish) sea-ice. For Arctic first year ice the modelled thickness sensitivity is less than half a meter. It reduces to a few centimeters for temperatures approaching the melting point. The campaign was conducted under unfavorable melting conditions and the spatial overlap between the L-band and EM-measurements was relatively small. Despite these disadvantageous conditions we demonstrate the possibility to measure the sea-ice thickness with the certain limitation up to 1.5 m. The ice thickness derived from SMOS measurements would be complementary to ESA's CryoSat-2 mission in terms of the error characteristics and the spatiotemporal coverage. The relative error for the SMOS ice thickness retrieval is expected to be not less than about 20%.
The European Society of Breast Cancer Specialists (EUSOMA) has fostered a voluntary certification process for breast centres to establish minimum standards and ensure specialist multidisciplinary ...care. Prospectively collected anonymous information on primary breast cancer cases diagnosed and treated in the units is transferred annually to a central EUSOMA data warehouse for continuous monitoring of quality indicators (QIs) to improve quality of care. Units have to comply with the EUSOMA Breast Centre guidelines and are audited by peers. The database was started in 2006 and includes over 110,000 cancers from breast centres located in Germany, Switzerland, Belgium, Austria, The Netherlands, Spain, Portugal and Italy. The aim of the present study is assessing time trends of QIs in EUSOMA-certified breast centres over the decade 2006–2015.
Previously defined QIs were calculated for 22 EUSOMA-certified breast centres (46122 patients) during 2006–2015.
On the average of all units, the minimum standard of care was achieved in 8 of 13 main EUSOMA QIs in 2006 and in all in 2015. All QIs, except removal of at least 10 lymph nodes at axillary clearance and oestrogen receptor–negative tumours (T > 1 cm or N+) receiving adjuvant chemotherapy, improved significantly in this period. The desirable target was reached for two QIs in 2006 and for 7 of 13 QIs in 2015.
The EUSOMA model of audit and monitoring QIs functions well in different European health systems and results in better performance of QIs over the last decade. QIs should be evaluated and adapted on a regular basis, as guidelines change over time.
•The time trends of quality indicators in EUSOMA-certified breast centres over the decade 2006–2015 are evaluated.•The EUSOMA model of audit and monitoring QIs functions well in different European health systems.•Audit and measuring quality indicators result in better performance.
Abstract Objective Misoprostol is safe and effective for labor induction in viable pregnancies. Little is known about the prevalence of off-label use of misoprostol, and the reasons for using or not ...using misoprostol for labor induction. As such, a national survey was conducted in Germany to assess reliable data about the use of misoprostol in clinical practice. Study design A prospective study was performed in 2013 using a standardized survey questionnaire. All registered departments of obstetrics and gynecology in Germany were targeted. Results Out of 783 questionnaires, 542 (69%) were returned. Three hundred and fifty-five (66%) respondents reported that they use misoprostol for labor induction in viable term pregnancies, and 183 (34%) respondents reported that they never use misoprostol for this indication. The most common reasons given for using misoprostol in labor induction were: effectiveness (40%), good patient acceptance (35%), established/well proven in clinical practice (35%) and cost-effectiveness (32%). The most common reasons given for not using misoprostol were lack of licence (off-label use, 69%) and uncertainty of the legal situation (27%). Conclusion Although misoprostol is not licensed in Germany for obstetric indications, the vast majority of respondents (66%) reported that they use misoprostol for labor induction. The main reasons for not using misoprostol for labor induction in Germany are legal concerns rather than lack of scientific evidence. Cost-effective medications with evidence-based effectiveness and safety should be supported by a clear statement from national medical societies.
Abstract
Objective:
Lipids and steroid hormones are closely linked. While cholesterol is the substrate for (placental) steroid hormone synthesis, steroid hormones regulate hepatic lipid production. ...The aim of this study was to quantify circulating steroid hormones and lipid metabolites, and to characterize their interactions in normal and pathological pregnancies with a focus on hepatic and placental pathologies.
Methods:
A total of 216 serum samples were analyzed. Group A consisted of 32 patients with uncomplicated pregnancies who were analyzed at three different time-points in pregnancy (from the first through the third trimester) and once post partum. Group B consisted of 36 patients (24th to 42nd week of gestation) with pregnancy pathologies (IUGR n = 10, preeclampsia n = 13, HELLP n = 6, intrahepatic cholestasis n = 7) and 31 controls with uncomplicated pregnancies. Steroid profiles including estradiol, progesterone, and dehydroepiandrosterone were measured by GC-MS and compared with lipid concentrations.
Results:
In Group A, cholesterol and triglycerides correlated positively with estradiol (cholesterol ρ = 0.50, triglycerides ρ = 0.57) and progesterone (ρ = 0.49, ρ = 0.53) and negatively with dehydroepiandrosterone (ρ = − 0.47, ρ = − 0.38). Smoking during pregnancy affected estradiol concentrations, leading to lower levels in the third trimester compared to non-smoking patients (p < 0.05). In Group B, cholesterol levels were found to be lower in IUGR pregnancies and in patients with HELLP syndrome compared to controls (p < 0.05). Steroid hormone concentrations of estradiol (p < 0.05) and progesterone (p < 0.01) were lower in pregnancies with IUGR.
Discussion:
Lipid and steroid levels were affected most in IUGR pregnancies, while only minor changes in concentrations were observed for other pregnancy-related disorders. Each of the analyzed entities displayed specific changes. However, since the changes were most obvious in pregnancies complicated by IUGR and only minor changes were observed in pregnancies where patients had impaired liver function, our data suggests that placental rather than maternal hepatic function strongly determines lipid and steroid levels in pregnancy.
Background. Infections with a low-risk type of human papillomavirus (HPV) may lead to genital warts. HPV targets the basal cell layer of epithelial cells. The first line of defense is the innate ...immune system, which provides nonspecific protection against a variety of pathogens. The antimicrobial peptides (AMPs) α-and β-defensins, cathelicidins, psoriasin, and RNase7 are central mediators. Methods. The expression of various α-and β-defensins, cathelicidin LL-37, psoriasin, and RNase7 was studied in biopsy samples from 35 patients with genital warts and 25 healthy women using quantitative real-time polymerase chain reaction and immunohistochemical analysis. Results. We found a significantly higher expression of the β-defensins hBD-1 (P = .03), hBD-2 (P < 0.01), and hBD-3 (P < .001), and psoriasin (P = .001) in condylomata acuminata, compared with normal controls. The RNA and protein levels of RNase7 did not differ between infected and uninfected samples (P = .55). The a-defensins HNP 1-3, HD5, and HD6 and the cathelicidin LL-37 were scarcely detectable in normal and infected tissue. Conclusions. The differing expression of AMPs in HPV-infected, compared with noninfected, vulvovaginal biopsy samples suggests that these peptides are important in the local immune response. Curiously, hBD-1 shows a significant induction whereas RNase7 does not, which suggests differing regulation of AMPs over the course of bacterial and viral infections.